Preliminary examination recommends tuberculosis antibody might be restricting COVID-19 passings Kumar Jeetendra | July 13, 2020 One of those emerging questions about this coronavirus that scientists have been attempting to understand is the reason developing countries are showing markedly lower rates of mortality in COVID-19 cases than anticipated. Research by assistant-professor Luis Escobar at this College of Natural Resources and Environment and 2 coworkers at the National Institutes of Health shows …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
Conceivable new anti-microbial created for drug-resistant pulmonary microorganism Kumar Jeetendra | December 9, 2020 Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as …
Poisonous pesticide transformed into treatment against antibiotic-resistant bacteria Kumar Jeetendra | December 30, 2020 They are used as pesticides and fungicides. However, these substances could be poisonous to humans and cause mutations. As they aren’t frequently used, there’s little data about them in the medicinal chemistry literature. However, it has been suggested recently that the groups of substances that are traditionally avoided can help to fight pathogenic bacteria. Yet, …
Study uncovers molecular mechanisms of drug resistance in Mycobacterium tuberculosis Kumar Jeetendra | April 9, 2021 A consortium of researchers from Russia, Belarus, Japan, Germany and France led by a Skoltech scientist have uncovered the way by which Mycobacterium tuberculosis survives in iron-deficient states by using rubredoxin B, a protein by a rubredoxin family that play an essential role in adaptation to changing environmental conditions. The new study is part of …
Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 – HaystackAnalytics Insights Kumar Jeetendra | March 23, 2022 Mumbai, 23 March 2022: HaystackAnalytics, a Mumbai based health-tech startup, supported by the Department of Science & Technology, Govt of India, healthcare veterans like Dr Velumani, and private players such as GE Healthcare and Intel India Startup Program, reported an alarming 49% increase in the number of TB infections across the country, which largely remain …
Lancet Report on Tuberculosis in the time of COVID-19 (1) shows tuberculosis case detection was reduced by 25·1% in India from 2019 Kumar Jeetendra | March 25, 2022 Mumbai, March 25, 2022: The global tuberculosis burden remains substantial, with more than 10 million people newly ill per year. Dr Zarir F Udwadia, the consultant chest physician at P.D. Hinduja Hospital & MRC, who co-authored the Lancet report that aims to review the interactions between COVID-19 and tuberculosis, including the population-level impact of COVID-19 on tuberculosis …
